FFCP PHASE1:Mm9::chr12:91051741..91051744,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=42|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:91051741..91051744,+|id=chr12:91051741..91051744,+|ontology_enrichment_celltype=CL:0002612!3.64e-07!3|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000970!5.14e-18!9;UBERON:0000019!5.14e-18!9;UBERON:0000047!5.14e-18!9;UBERON:0004088!5.14e-18!9;UBERON:0002104!5.14e-18!9;UBERON:0001456!5.14e-18!9;UBERON:0003072!5.14e-18!9;UBERON:0003071!5.14e-18!9;UBERON:0004128!5.14e-18!9;UBERON:0001444!6.63e-15!11;UBERON:0000020!9.79e-14!12;UBERON:0001032!9.79e-14!12;UBERON:0004456!9.79e-14!12;UBERON:0005085!9.58e-13!13;UBERON:0002257!3.64e-07!3;UBERON:0003076!6.76e-07!12;UBERON:0003057!6.76e-07!12;UBERON:0002346!9.98e-07!71;UBERON:0003075!9.98e-07!71;UBERON:0007284!9.98e-07!71|ontology_enrichment_uberon_v019_2=UBERON:0002037,6.52e-23,4;UBERON:0002680,6.52e-23,4;UBERON:0001895,6.52e-23,4;UBERON:0010092,6.52e-23,4;UBERON:0006215,6.52e-23,4;UBERON:0004733,8.02e-16,6;UBERON:0004732,8.02e-16,6;UBERON:0002028,8.02e-16,6;UBERON:0007277,8.02e-16,6;UBERON:0003076,1.13e-08,12;UBERON:0003057,1.13e-08,12|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142371680799103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.44561437714983,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0680364991513279,0.12811372028485,0.0937017245597288,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:91051741..91051744,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=42 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:91051741..91051744,+ | |||
|description=CAGE_peak_at_chr12:91051741..91051744,+ | |||
|id=chr12:91051741..91051744,+ | |||
|ontology_enrichment_celltype=CL:0002612!3.64e-07!3 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000970!5.14e-18!9;UBERON:0000019!5.14e-18!9;UBERON:0000047!5.14e-18!9;UBERON:0004088!5.14e-18!9;UBERON:0002104!5.14e-18!9;UBERON:0001456!5.14e-18!9;UBERON:0003072!5.14e-18!9;UBERON:0003071!5.14e-18!9;UBERON:0004128!5.14e-18!9;UBERON:0001444!6.63e-15!11;UBERON:0000020!9.79e-14!12;UBERON:0001032!9.79e-14!12;UBERON:0004456!9.79e-14!12;UBERON:0005085!9.58e-13!13;UBERON:0002257!3.64e-07!3;UBERON:0003076!6.76e-07!12;UBERON:0003057!6.76e-07!12;UBERON:0002346!9.98e-07!71;UBERON:0003075!9.98e-07!71;UBERON:0007284!9.98e-07!71 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002037,6.52e-23,4;UBERON:0002680,6.52e-23,4;UBERON:0001895,6.52e-23,4;UBERON:0010092,6.52e-23,4;UBERON:0006215,6.52e-23,4;UBERON:0004733,8.02e-16,6;UBERON:0004732,8.02e-16,6;UBERON:0002028,8.02e-16,6;UBERON:0007277,8.02e-16,6;UBERON:0003076,1.13e-08,12;UBERON:0003057,1.13e-08,12 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.142371680799103,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.44561437714983,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0680364991513279,0.12811372028485,0.0937017245597288,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:91051741..91051744,+ | |||
}} |
Latest revision as of 11:24, 5 August 2015
Short description: | p@chr12:91051741..91051744, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:91051741..91051744, + |
Coexpression cluster: | MCL_coexpression_mm9:42 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cerebellum | 6.52e-23 | 4 |
regional part of metencephalon | 6.52e-23 | 4 |
metencephalon | 6.52e-23 | 4 |
future metencephalon | 6.52e-23 | 4 |
rhombic lip | 6.52e-23 | 4 |
segmental subdivision of hindbrain | 8.02e-16 | 6 |
segmental subdivision of nervous system | 8.02e-16 | 6 |
hindbrain | 8.02e-16 | 6 |
presumptive hindbrain | 8.02e-16 | 6 |
posterior neural tube | 1.13e-08 | 12 |
chordal neural plate | 1.13e-08 | 12 |